A 61-year-old woman with diabetes and sciatica started prednisone 10 mg twice daily for five days and now has a home glucose of 400 mg/dL; how should I manage her hyperglycemia and steroid therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Steroid-Induced Hyperglycemia in a Diabetic Patient

Stop the twice-daily prednisone dosing immediately and switch to once-daily morning administration (20 mg in the morning), then start NPH insulin 0.3-0.5 units/kg given in the morning to match the steroid's peak hyperglycemic effect. 1

Immediate Actions

Modify Prednisone Dosing Schedule

  • The current twice-daily dosing regimen is exacerbating hyperglycemia unnecessarily 2
  • Consolidate to a single 20 mg morning dose (before 9 am) to minimize adrenal suppression and create a more predictable hyperglycemic pattern 2
  • Morning dosing causes peak hyperglycemia 6-9 hours later (afternoon), which often normalizes overnight even without treatment 3, 1
  • This dosing change maintains the same total daily dose while improving glycemic control 3

Initiate NPH Insulin Therapy

  • Start NPH insulin at 0.3-0.5 units/kg/day given in the morning (for a 70 kg patient, this would be approximately 21-35 units) 1
  • The American Diabetes Association specifically recommends NPH insulin because its intermediate-acting profile aligns with prednisone's peak hyperglycemic effect occurring 6-9 hours post-dose 3, 1
  • Target blood glucose range of 100-180 mg/dL (5.6-10.0 mmol/L) 1

Monitoring Strategy

Glucose Monitoring Schedule

  • Monitor blood glucose four times daily, with particular attention to afternoon readings (2-4 pm) when steroid effects peak 1, 4
  • The hyperglycemic effect is most pronounced 6-9 hours after steroid administration 1, 4
  • Fasting glucose measurements will miss the peak hyperglycemic effect and underestimate severity 4
  • Daily monitoring is recommended for glucose levels >180 mg/dL (10 mmol/L) 3

Critical Considerations for the 5-Day Course

Tapering Insulin as Steroids End

  • As the prednisone course completes, insulin doses must be proportionally decreased to avoid hypoglycemia 1
  • This is a common pitfall—failure to reduce insulin as steroids taper can lead to severe hypoglycemia 1
  • After steroid discontinuation, many patients return to baseline glucose control, as corticosteroid-induced hyperglycemia is often reversible 1
  • If hyperglycemia persists after steroid discontinuation, the patient likely had underlying uncontrolled type 2 diabetes that was unmasked rather than true steroid-induced diabetes 1

Why This Approach Over Alternatives

NPH vs. Other Insulin Regimens

  • While basal-bolus regimens are sometimes used, NPH insulin is specifically preferred for once-daily short-acting steroids like prednisone because its pharmacokinetic profile matches the steroid's hyperglycemic pattern 3, 1
  • Long-acting basal insulins (glargine, detemir) would provide 24-hour coverage that is unnecessary since glucose often normalizes overnight 3, 1

Oral Agents Are Insufficient

  • With glucose at 400 mg/dL, oral agents alone (including metformin) are inadequate for this degree of hyperglycemia 1, 4
  • Insulin therapy is required when glucose levels persistently exceed 200 mg/dL 4
  • Temporary adjustments to existing diabetes medications are only sufficient for mild hyperglycemia 4

Pathophysiology Context

  • Prednisone causes hyperglycemia through three mechanisms: impaired beta cell insulin secretion, increased total body insulin resistance, and enhanced hepatic gluconeogenesis 3, 4
  • The degree of hyperglycemia correlates directly with steroid dose—higher doses cause more significant elevations 3, 1
  • Patients with pre-existing diabetes (like this patient) experience more pronounced hyperglycemic effects 3, 4

Safety Considerations

  • Corticosteroid-induced hyperglycemia occurs in 56-86% of hospitalized patients and 42-72% of patients with pre-existing diabetes experience worsening hyperglycemia 1
  • Severe hyperglycemia can lead to osmotic diuresis, hypovolemia, impaired wound healing, and increased infection risk 4
  • The short 5-day course limits long-term complications but requires aggressive short-term management 1

References

Guideline

Corticosteroid-Induced Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Corticosteroid-Induced Hyperglycemia with Prednisolone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Corticosteroid-Induced Hyperglycemia Mechanisms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.